Results 71 to 80 of about 5,025 (229)
Linfoma Não Hodgkin de Células T Citotóxico: uma Apresentação Clínica Atípica [PDF]
, 2013 Cytotoxic lymphomas comprise a spectrum of peripheral T-cell lymphomas that can have a initial or late cutaneous presentation. We describe a 46-year-old man from Cape Verde, with a dermatosis involving his face and trunk, consisting of monomorphic ...
Afonso, A +5 more
core +3 more sources
Synthesis and Antiproliferative Activity of Cisplatin‐3–Chloropiperidine Conjugates
ChemBioChem, Volume 25, Issue 23, December 2, 2024.Synthesis and characterization of two novel cisplatin‐ alkylating agents conjugates. Combining cisplatin with a sterically demanding cyclic nitrogen mustard. Cytotoxicity of the ligands and the complexes examined with MTT assays. The novel conjugates displayed a high antiproliferative potency against 5 human cancer cell lines.
Mats Georg +5 more
wiley +1 more source
An overview of different methods to establish a murine premature ovarian failure model
Animal Models and Experimental Medicine, Volume 7, Issue 6, Page 835-852, December 2024.Ten different methods to induce murine POF models: (1) POF model induced by chemotherapy drugs, (2) radiotherapy‐induced POF model, (3) genetically induced POF model, (4) POF model induced by D‐galactose, (5) natural ovarian aging (NOA)‐induced POF model (6) physiological POF model with consecutive superovulation, (7) oophorectomy POF model, (8) POF ...
Negar Pouladvand +4 more
wiley +1 more source
Recent Advances in Cancer Chemotherapy [PDF]
, 1981 The present state of cancer chemotherapy can be reviewed in light of selected basic principles with an acknowledgement of the role of established chemotherapeutic agents.
Diasio, Robert B.
core +1 more source
The Concept of Divergent Targeting through the Activation and Inhibition of Receptors as a Novel Chemotherapeutic Strategy: Signaling Responses to Strong DNA-Reactive Combinatorial Mimicries [PDF]
, 2012 Recently, we reported the combination of multitargeted ErbB1 inhibitor–DNA damage combi-molecules with OCT in order to downregulate ErbB1 and activate SSTRs.
Jean-Claude, Bertrand J. +2 more
core +3 more sources
Plant‐Based Anticancer Compounds With a Focus on Breast Cancer
Cancer Reports, Volume 7, Issue 10, October 2024.ABSTRACT Breast cancer is a common form of cancer among women characterized by the growth of malignant cells in the breast tissue. The most common treatments for this condition include chemotherapy, surgical intervention, radiation therapy, hormone therapy, and biological therapy.
Amin Moradi Hasan‐Abad +4 more
wiley +1 more source
Mediterranean Journal of Hematology and Infectious Diseases, 2014 Patients with Hodgkin lymphoma treated with DNA-breaking alkylating agents such as mechlorethamine and procarbazine in the MOPP regimen and with topoisomerase II inhibitors, such as etoposide did show a long-term risk of developing therapy-related ...
Ercole Brusamolino +2 more
doaj
A comparative analysis of DNA molecular crosslinking by dichloro-N-substituted azaadamantane isomers [PDF]
, 1985 A series of anti, anti-dichloro-N-substituted azaadamantanes have been synthesized (Henkel et al, 1981, J. Org. Chem. , 46, 3483) representing conformationally rigid nitrogen mustards incorporated into an adamantyl framework with well defined ...
Robbins, Harry
core +1 more source
JEADV Clinical Practice, Volume 4, Issue 2, Page 552-555, June 2025.
Michelle Raaijmakers +5 more
wiley +1 more source
British Journal of Haematology, Volume 205, Issue 4, Page 1374-1382, October 2024.The therapeutic paradigm in Hodgkin lymphoma has shifted. Study of long‐term cause‐specific mortality in Danish patients show that we cure more patients and see less treatment‐related mortality. Summary The documented treatment‐induced excess mortality in Hodgkin lymphoma (HL) has spurred important treatment changes over recent decades.
Sára Rossetti +12 more
wiley +1 more source